Home > Clinical Trials
Check All Search

Saved trials

ACTIVE_NOT_RECRUITING
NCT03129555
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
5,000 Enrollment(s)
26 Study location(s)
INTERVENTIONAL (PHASE4)
Deep Vein Thrombosis


Pulmonary Embolism
RECRUITING
NCT06957366
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
920 Enrollment(s)
14 Study location(s)
INTERVENTIONAL (NA)
Atrial Fibrillation (AF)


VTE
ACTIVE_NOT_RECRUITING
NCT04622319
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)
1,600 Enrollment(s)
481 Study location(s)
INTERVENTIONAL (PHASE3)
HER2-Positive Primary Breast Cancer


Residual Invasive Breast Cancer
TERMINATED
NCT06231693
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
2 Enrollment(s)
2 Study location(s)
OBSERVATIONAL (None)
Breast Cancer
RECRUITING
NCT06100874
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
40 Enrollment(s)
4 Study location(s)
INTERVENTIONAL (PHASE2)
Her 2 Positive Breast Cancer


Breast Cancer Female


Breast Cancer Metastatic
ACTIVE_NOT_RECRUITING
NCT03273413
Statin Therapy in Patients With Early Stage ADPKD
150 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
ADPKD


Autosomal Dominant Polycystic Kidney
NOT_YET_RECRUITING
NCT06899126
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
686 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Non-small Cell Lung Cancer
RECRUITING
NCT06409390
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
15 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (EARLY_PHASE1)
Metastatic Breast Cancer